Provided by Tiger Fintech (Singapore) Pte. Ltd.

Instil Bio, Inc.

15.03
+0.85005.99%
Post-market: 15.030.00000.00%16:10 EDT
Volume:47.99K
Turnover:694.14K
Market Cap:98.08M
PE:-1.32
High:15.03
Open:14.09
Low:13.61
Close:14.18
Loading ...

Turnstone Biologics Corp. Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights

GlobeNewswire
·
13 Nov 2024

Instil Bio Inc expected to post a loss of $2.11 a share - Earnings Preview

Reuters
·
08 Nov 2024

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024

GlobeNewswire
·
08 Nov 2024

High Growth Tech Stocks to Watch in November 2024

Simply Wall St.
·
05 Nov 2024

Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

GlobeNewswire
·
05 Nov 2024

JMP Securities Initiates Instil Bio at Market Perform

MT Newswires Live
·
04 Nov 2024

Instil Bio, Inc.'s (NASDAQ:TIL) stock price dropped 18% last week; private equity firms would not be happy

Simply Wall St.
·
04 Nov 2024

Instil Bio Initiated at Market Perform by JMP Securities

Dow Jones
·
04 Nov 2024

Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2024 Financial Results Conference Call and Webcast on Thursday, November 7, 2024

GlobeNewswire
·
01 Nov 2024

Lyell Immunopharma to Acquire ImmPACT Bio and Prioritizes its Pipeline to Focus on Next-Generation CAR T-cell Therapies

GlobeNewswire
·
25 Oct 2024

Summit Stock Skyrockets Nearly 700% YTD: Time to Sell or Hold?

Zacks
·
23 Oct 2024

Is Iovance Biotherapeutics Inc. (IOVA) the Most Promising Stock to Buy According to Wall Street Analysts?

Insider Monkey
·
17 Oct 2024

Till Capital Announces AGM Results and Leadership Changes

TIPRANKS
·
16 Oct 2024